Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Seminars in Oncology|June 14, 2002
Issues in clinical trial design for tumor marker studiesDaniel Sargent, Carmen AllegraTherapeutic Advances in Medical Oncology|November 3, 2012
Antiangiogenesis therapy in the treatment of metastatic colorectal cancerAxel Grothey, Carmen AllegraOncology (Williston Park, N.Y.)|June 16, 2006
General and statistical hierarchy of appropriate biologic endpointsDaniel SargentGastrointestinal Cancer Research : GCR|April 4, 2009
Genomic classifiers in colon cancer - clinical utilityDaniel SargentThe Oncologist|March 19, 2010
What constitutes reasonable evidence of efficacy and effectiveness to guide oncology treatment decisions?Daniel SargentThe Oncologist|June 24, 2006
End points for adjuvant therapy trials: has the time come to accept disease-free survival as a surrogate end point for overall survival?Sharlene Gill, Daniel SargentStatistics in Medicine|April 20, 2016
Testing of evaluation bias for progression free survival endpoint in oncology clinical trialsYan Sun, Wenting Wu, Daniel SargentJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Clinical trial designs for predictive marker validation in cancer treatment trialsDaniel J Sargent, Barbara A Conley, Carmen Allegra, et al.Cardio-Oncology (London, England)|March 11, 2020
5-FU induced cardiotoxicity: case series and review of the literatureCai Yuan, Hiral Parekh, Carmen Allegra, et al.Pageof 5